Weight-loss drugs may redefine beauty in art, experts say
Experts anticipate that weight-loss medications such as Wegovy and Mounjaro will alter beauty standards in art, leading to a trend termed 'GLP-1 face,' characterized by emaciated features. At the European Congress on Obesity in Istanbul, Dr. Michael Yafi from the University of Texas, Houston, shared findings indicating that art will increasingly portray slimmer figures with aged appearances due to rapid fat reduction. He suggested that Picasso might have embraced this emerging aesthetic. Prof. Rosalind Gill drew comparisons to the 'heroin chic' trend of the 1990s. While art historically celebrated larger bodies, the mid-20th century marked a shift towards idealizing thinness. Yafi highlighted the importance of recognizing evolving beauty norms for compassionate obesity treatment.
Key facts
- GLP-1 drugs like Wegovy and Mounjaro are changing perceptions of beauty in art.
- Dr Michael Yafi presented research at the European Congress on Obesity in Istanbul.
- Yafi predicts 'GLP-1 face' will be depicted in future artworks.
- Prof Rosalind Gill compared the trend to 'heroin chic' and Aids-era imagery.
- Historically, high BMI was portrayed positively in art as a sign of wealth.
- Mona Lisa is cited as an example of a high-BMI subject in art.
- Art historian Bendor Grosvenor cautioned against diagnosing historical figures.
- The shift toward thin ideals began in the mid-20th century due to medical discoveries.
Entities
Artists
- Mona Lisa
- Leonardo da Vinci
- Fernando Botero
- Picasso
- Rubens
- Renoir
Institutions
- University of Texas, Houston
- European Congress on Obesity
- British Academy
- Goldsmiths
- Louvre
- The Guardian
Locations
- Istanbul
- Houston
- United States